EW:NYSE
Edwards Lifesciences Corp
85,61 $
arrow_downward
-0,91%(-0,79) 1D
13 հոկ, 12:15:40 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EW...
Open
86,55 $
High
86,77 $
Low
85,24 $
Mkt. cap
49,35 մլրդ
Avg. vol.
3,50 մլն
Volume
751,13 հզր
P/E ratio
49,53
52-wk high
96,29 $
52-wk low
72,40 $
EPS
1,73 $
Beta
0,87
Shares outstanding
576,40 մլն
No. of employees
16 հզր
Open
86,55 $
High
86,77 $
Low
85,24 $
Mkt. cap
49,35 մլրդ
Avg. vol.
3,50 մլն
Volume
751,13 հզր
P/E ratio
49,53
52-wk high
96,29 $
52-wk low
72,40 $
EPS
1,73 $
Beta
0,87
Shares outstanding
576,40 մլն
No. of employees
16 հզր
News stories
From web sources and news partners
News Corp
·
19 ժամ առաջ
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors despite daily gains
www.dars.gov.et
·
21 ժամ առաջ
EW Q2 2026 Earnings: Edwards Lifesciences Beats EPS Estimate as Shares Edge Higher - Management Guidance Update
Barchart.com
·
1 օր առաջ
Edwards Lifesciences Earnings Preview: What to Expect
Profile
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
About Edwards Lifesciences Corp
CEO-
Employees16 հզր
Founded1958
HeadquartersԻրվայն, Կալիֆոռնիա, Միացյալ Նահանգներ
Sector-
Websiteedwards.com